Knowledge Transfer Ireland (KTI) Impact Awards in Dublin – recognition for SurgaColl!

Six innovation projects from Ireland’s research and technology sectors won prizes at the annual Knowledge Transfer Ireland (KTI) Impact Awards in Dublin on Thursday. The Royal College of Surgeons Ireland was awarded the “Spin-out Company” award for SurgaColl. The awards were presented by John Halligan, the Minister of State for Training, Skills, Innovation, Research and […]

Stephen Cook joins the team

We are delighted to announce that Stephen Cook has joined the SurgaColl UK based team as Clinical Research Associate with effect March 2018. Stephen is an accomplished and experienced Clinical Research leader with 18 years of working experience, encompassing Medical Devices and Pharma. He has a very strong understanding and insight of processes in the […]

ICRS 2018 – 14th World Congress, Macau, China

Dr John Gleeson will be attending the ICRS (International Cartilage Repair Society) Congress in Macau, China from 9th to 12th April. Their mission is to advance science and education in the field of cartilage repair and regenerative medicine worldwide. Held for the first time in Asia, the ICRS 2018 will provide a networking opportunity for the […]

The MedTech Strategist, Dublin April 2018

Our CEO, Bill Allan will be attending The MedTech Strategist in Dublin 17-19 April. This exceptional investment and networking event is recognised by the medical device industry as the leading medical technology investment forum in Europe. Click here for further information about the event.      

Brian Duffy joins SurgaColl as Operations Director

We are very pleased to announce the appointment of Brian Duffy as Operations Director, reporting directly to Bill Allan, CEO. Brian has great experience in the medical industry and has worked for Abbott, Medtronic and Boston Scientific in senior operational roles and has led significant projects. Brian is an ASQ certified Six Sigma black belt […]

Read the latest blog from Biotech and Money

Biotech and Money is the influential community of senior life science decision makers and the Drugs & Dealers Blog provides genuine thought leadership, exclusive executive insight and market intelligence on the life science and healthcare investment sector. Click here to read the latest blog reporting on Surgacoll’s £3.1M Series A investment to drive next phase […]

Dr Paul Bielderman joins SurgaColl as Medical Director

We are very pleased to announce the appointment of Dr Paul Bielderman as Medical Director reporting directly to the CEO. Paul has a long heritage as a physician in the medical industry and has worked in both devices and pharma in a range of Medical Affairs and Medical Director roles, including Covidien (now Medtronic), Kyphon […]

SurgaColl Holdings formed and Series A Funding round completed

SurgaColl technologies Ltd has completed a  corporate restructuring and established a UK based holding company, SurgaColl Holdings Ltd and closed a £3.1m funding round led by Catapult Ventures (see detail below). The funds will be used to continue clinical evidence development, product development and building a world class team. Click here to read the full […]

John Hoare joins SurgaColl as QA/RA Manager and member of Leadership Team

We are very pleased to announce the appointment of John Hoare as QA/RA Manager for SurgaColl Ltd reporting directly to the CEO. John has strong experience in both Quality Affairs and Regulatory Affairs, in the Medical Device and Pharma sectors and joins us from Bausch and Lomb. He has had US and Canada based experience […]

European Grant (Horizon 2020) awarded to SurgaColl

SurgaColl technologies has been awarded a European Grant (Horizon 2020) as part of a consortium of organisations working towards ‘Controlling Cartilage to Bone Transitions for improved Treatment of Bone defects and Osteoarthritis’. The consortium  is led by Erasmus University in Rotterdam and includes IRCCS in Genoa, Trinity College Dublin, Klinikum der Universität zu Köln, Royal Veterinary College, […]